Plain-English translation of NCT00682032 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is studying beta-glucan (Imucell WGP), a dietary supplement made from food-grade baker's yeast that may help boost your immune system's ability to fight lung cancer. Animal studies have shown that this medication can trigger white blood cells to destroy cancer cells, and when combined with anti-cancer drugs, it may help shrink tumors. The researchers want to understand how this treatment works in people with non-small cell lung cancer.
Current lung cancer treatments work in different ways, but researchers believe the immune system could be a powerful partner in fighting the disease. This study exists to test whether this medication can activate your body's natural cancer-fighting defenses and potentially improve treatment outcomes.
You likely qualify if…
You likely don't qualify if…
Depending on which part of the study you join, you would take one 250 mg capsule of the supplement three times a day for 10 to 20 days. During this time, researchers will monitor your health and may collect blood samples to see how your immune system is responding. The study involves visits to the research center, and you'll work closely with the medical team to track any effects of the medication.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Sponsor
University of Louisville
Collaborators
James Graham Brown Cancer Center
Enrollment target
~300 participants
Started
October 2008
Primary completion
April 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Clinical Trials Office, Brown Cancer Center
James Graham Brown Cancer Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.